Presentation ACC 2014 Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer Presenter: Masahiro Natsuaki March 31, 2014
News Conference News ACC 2014 ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates Yael L. Maxwell March 31, 2014
News Conference News ACC 2014 NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus Jason Kahn March 31, 2014
News Conference News ACC 2013 Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months Jason Kahn March 11, 2013
Presentation ACC 2013 One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer Presenter: Masahiro Natsuaki March 09, 2013
News Conference News ACC 2013 Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES Jason Kahn March 09, 2013
News Conference News ACC 2012 Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES L.A. McKeown March 26, 2012
News Conference News ACC 2012 Adjunctive Cilostazol Noninferior to Double-Dose Clopidogrel in All-Comer PCI Trial L.A. McKeown March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
Presentation ACC 2012 Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention Presenter: Robert A. Byrne March 24, 2012